Scleroderma and alveolar inflammation;SCLERODERMIE ET INFLAMMATION ALVEOLAIRE

Revue des Maladies Respiratoires

Volumn 13, Issue 1, 1996, Pages 15-20

  Crestani, B ^a   Aubier, M ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

alveolar macrophages; interleukin 6; interleukin 8; scleroderma

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8;

CONTROLLED STUDY; HUMAN; LUNG ALVEOLITIS; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; MACROPHAGE ACTIVATION; NEUTROPHIL; PNEUMONIA; REVIEW; SCLERODERMA; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; LEUKOCYTE ACTIVATION; MONOCYTE; PATHOLOGY; SYSTEMIC SCLEROSIS;

CASE-CONTROL STUDIES; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MACROPHAGE ACTIVATION; MACROPHAGES, ALVEOLAR; MONOCYTES; NEUTROPHIL ACTIVATION; NEUTROPHILS; PULMONARY FIBROSIS; SCLERODERMA, SYSTEMIC;

EID: 0029890326     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. LEROY E : Scleroderma (Systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
2. MEDSGER TA, MASI AT, RODNAN GP, BENEDEK TG, ROBINSON H : Survival with systemic sclerosis. Ann Intern Med 1971;75:369-76.
3. D'ANGELO W, FRIES J, MASI A, SHULMAN L : Pathologic observations in systemic sclerosis (scleroderma): a study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969;46:428-40.
4. LEE P, LANGEVITZ P, ALDERDICE C et al : Mortality in systemic sclerosis (scleroderma). Q J Med 1992;82:139-48.
5. SILVER RM, MILLER KS : Lung involvement in systemic sclerosis. Rheum Dis Clin North Am 1990;16:199-216.
6. WIEDEMANN H, MATTHAY R : Pulmonary manifestations of the collagen vascular diseases. Clin Chest Med 1989;10:677-722.
7. POSTLETHWAITE AE : Early immune events in scleroderma. Rheum Dis Clin North Am 1990;16:125-39.
8. KAHALEH MB : Vascular disease in scleroderma. Endothelial T lymphocyte-fibroblast interactions. Rheum Dis Clin North Am 1990;16:53-73.
9. HARRISON N, MYERS A, CORRIN B et al. : Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis 1991;144:106-13.
10. WELLS AU, CULLINAN P, HANSELL DM et al. : Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1994;149:1583-90.
11. CORRIN B, DEWAR A, RODRIGUES-ROISIN R, TURNER-WARWICK M : Fine structural changes in cryptogenic fibrosing alveolitis and asbestosis. J Pathol 1985;147:107-19.
12. EDELSON J, HYLAND R, RAMSDEN M et al. : Lung inflammation in scleroderma: clinical, radiographic, physiologic and cytopathological features. J Rheumatol 1985;12:957-63.
13. WALLAERT B, HATRON PY, GROSBOIS JM, TONNEL AB, DEVULDER B, VOISIN C : Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Am Rev Respir Dis 1986;133:574-80.
14. SILVER RM, MILLER KS, KINSELLA M, SMITH EA, SCHABEL SI : Evaluation and management of scleroderma lung disease using bronchoalveolar lavage. Am J Med 1990;88:470-6.
15. WALLAERT B : L'alvéolite latente des maladies systémiques. Transition entre le normal et le pathologique. Rev Mal Respir 1990;7:17-25.
16. MORELAND LW, GOLDSMITH KT, RUSSEL WJ, YOUNG KR, GARVER RI : Transforming growth factor β within fibrotic scleroderma lung. Am J Med 1992;93:628-36.
17. BREIT S, CAIRNS D, SZENTIRMAY A et al. : The presence of Sjögren's syndrome is a major determinant of the pattern of interstitial lung disease in scleroderma and other connective tissue diseases. J Rheumatol 1989;16:1043-9.
18. OWENS GR, PARADIS IL, GRYZAN S et al. : Role of inflammation in the lung disease of systemic sclerosis: comparison with idiopathic pulmonary fibrosis. J Lab Clin Med 1986;107:253-60.
19. WELLS AU, HANSELL DM, CORRIN B et al. : High resolution computed tomography as a predictor of lung histology in systemic sclerosis. Thorax 1992;47:738-42.
20. WARRICK J, BHQLLA M, SCHABEL S, SILVER R : High resolution computed tomography in early scleroderma lung disease. J Rheumatol 1991;18:1520-8.
21. ROSSI GA, BITTERMAN PB, RENNARD SI, FERRANS VJ, CRYSTAL RG : Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis. Am Rev Respir Dis 1985;131:612-17.
22. CROUCH E : Pathobiology of pulmonary fibrosis. Am J Physiol (Lung Cell Mol Physiol 3) 1990;259:L159-84.
23. CRYSTAL R, FERRANS V, BASSET F : Biologic basis of pulmonary fibrosis. In: RG Crystal, JB West, PJ Barnes, NS Cherniack and ER Weibel, eds. The Lung: scientific foundations. New York: Raven Press, Ltd, 1991;2031-46.
24. BITTERMAN P, RENNARD S, KEOGH B, WEWERS M, ADELBERG S, CRYSTAL R : Familial idiopathic pulmonary fibrosis: evidence of lung inflammation in unaffected family members. N Engl J Med 1986;314:1343-7.
25. FINE A, GOLDSTEIN R, SNIDER G : Animal models of pulmonary fibrosis. In: RG Crystal, JB West, PJ Barnes, NS Cherniack and ER Weibel, eds. The Lung: scientific foundations. New York: Raven Press, Ltd, 1991;2047-57.
26. BRANDES M, FINKELSTEIN J : Stimulated rabbit alveolar macrophages secrete a growth factor for type II pneumocytes. Am J Respir Cell Mol Biol 1989;1:101-9.
27. CRESTANI B, CORNILLET P, DEHOUX M, ROLLAND C, GUENOUNOU M, AUBIER M : Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo. J Clin Invest 1994;94:731-9.
28. KINSELLA MB, SMITH EA, KS M, LEROY EC, SILVER RM : Spontaneous production of fibronectin by alveolar macrophages in patients with scleroderma. Arthritis Rheum 1989;32:577-83.
29. MILLER KS, SMITH EA, KINSELLA M, SCHABEL SI, SILVER RM : Lung disease associated with progressive systemic sclerosis. Am Rev Respir Dis 1990;141:301-6.
30. WALLAERT B, BART F, AERTS C et al. : Activated alveolar macrophages in subclinical pulmonary inflammation in collagen vascular diseases. Thorax 1988;43:24-30.
31. KUNKEL SL, STANDIFORD T, KASHARA K, STRIKTER RM : Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp Lung Res 1991;17:17-23.
32. CRESTANI B, SETA N, PALAZZO E et al. : Interleukin-8 and neutrophils in systemic sclerosis with lung involvement. Am J Respir Crit Care Med 1994;150:1363-7.
33. CRESTANI B, SETA N, DE BANDT M et al. : Interleukin-6 secretion by monocytes and alveolar macrophages in systemic sclerosis with lung involvement. Am J Respir Crit Care Med 1994;149:1260-5.
34. CRESTANI B, ROLLAND C, PETIET A, COLAS-LINHART N, AUBIER M : Cell surface carbohydrates modulate neutrophil adherence to alveolar type II cells in vitro. Am J Physiol (Lung Cell Mol Physiol 8) 1993;264:L391-L400.
35. SIMON R, DEHART P, TODD III R : Neutrophil-induced injury of rat alveolar epithelial cells. J Clin Invest 1986;78:1375-86.
36. ROSCHMANN R, ROTHENBERG R : Pulmonary fibrosis in rheumatoid arthritis: a review of clinical features and therapy. Semin Arthritis Rheum 1987;16:174-85.
37. XING Z, BRACIAK T, JORDANA M, CROITORU K, GRAHAM F, GAULDIE J : Adcnovirus-mediated cytokine gene transfer at tissue sites. Overexpression of IL-6 induces lymphocytic hyperplasia in the lung. J Immunol 1994;153:4059-69.
38. CAMPBELL P, LEROY E : Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum 1975;4:351-68.
39. KAHALEH MB : Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic action. Arthritis Rheum 1991;34:978-83.
40. KAHALEH MB, LEROY EC : Endothelial injury in scleroderma. J Lab Clin Med 1983;101:199-216.
41. FURST D, CLEMENTS P, GRAZE P : A syndrome resembling progressive systemic sclerosis after bone marrow transplantation: a model for scleroderma? Arthritis Rheum 1979;22:904-10.
42. POPE J : Treatment of systemic sclerosis. Curr Opinion Rheumatol 1993;5:792-801.
43. FREUNDLICH B, JIMENEZ S, STEEN V, MEDSGER T, SZOLNICKJI M, JAFFE S : Treatment of systemic sclerosis with recombinant interferon-gamma. Arthitis Rheum 1992;35:1134-41.
44. HEIN R, BEHR J, HUNDGEN M et al. : Treatment of systemic sclerosis with gamma-interferon. Br J Dermatol 1992;126:496-501.
45. STEVENS W, VANCHEESWARAN R, BLACK C, and the UK Systemic Sclerosis Study Group : Alpha interferon-2a (Roferon-a) in the treatment of diffuse cutaneous systemic sclerosis: a pilot study. Br J Rheumatol 1992;31:683-9.